Overview

Lipid and Adipokine Profiles Following Subcutaneous Injection of ATX-101 Into Abdominal Fat Tissue

Status:
Completed

Trial end date:
2011-01-01

Target enrollment:

Participant gender:

Summary

Open Label Study to Evaluate the Serum Lipid and Adipokine Profiles Following Subcutaneous Injection of ATX-101 into Abdominal Fat Tissue

Phase:

Phase 1

Details

Lead Sponsor:

Kythera Biopharmaceuticals